DescriptionTestosterone levels with 300 mg per week cyproterone acetate and 100 mg per month estradiol undecylate by intramuscular injection.png
English: In men with prostate cancer. Averages are solid lines. Upper/lower bounds (i.e., maximums/minimums) are dashed lines. In the cyproterone acetate group, testosterone levels decreased from 434 ng/dL to 107 ng/dL after 3 months and to 102 ng/dL after 6 months. Hence, testosterone levels decreased by about 75% in the cyproterone acetate group. In the estradiol undecylate group, testosterone levels decreased from 416 ng/dL to 38 ng/dL after 3 months and to 30 ng/dL after 6 months. Hence, testosterone levels decreased by about 91% in the estradiol undecylate group.
(1980). "Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial". Br J Urol52 (3): 208–15. DOI:10.1111/j.1464-410X.1980.tb02961.x. PMID7000222.
The person who associated a work with this deed has dedicated the work to the public domain by waiving all of their rights to the work worldwide under copyright law, including all related and neighboring rights, to the extent allowed by law. You can copy, modify, distribute and perform the work, even for commercial purposes, all without asking permission.
http://creativecommons.org/publicdomain/zero/1.0/deed.enCC0Creative Commons Zero, Public Domain Dedicationfalsefalse
Original upload log
The original description page was here. All following user names refer to en.wikipedia.
== Summary == I made this, anyone can use it. In men with prostate cancer. Averages are solid lines. Upper/lower bounds (i.e., maximums/minimums) are dashed lines. Source of the values: {{cite journal | vauthors = Jacobi GH, Altwein JE, Kurth KH, Bas...
Captions
Add a one-line explanation of what this file represents